Weekly market report: June 6, 2024

Weekly market report: June 6, 2024

USA

Most of the major benchmarks closed lower over the holiday-shortened week but rounded out a month of gains. In contrast to much of the month, small-caps performed better than large-caps, and value stocks held up better than growth shares. The technology-heavy Nasdaq Composite was especially weak, due in part to a sharp decline in cloud software provider Salesforce, which fell sharply after releasing first-quarter revenues that missed consensus estimates. Markets were shuttered Monday in observance of the Memorial Day holiday.

The catalysts for the week’s moves were arguably harder to detect than usual. Much of the week’s relatively light economic calendar came in roughly in line with expectations, most notably the Commerce Department’s personal consumption expenditure (PCE) price index report, released Friday morning. Core (less food and energy) PCE prices—widely considered the Federal Reserve’s preferred inflation gauge—rose 0.2% in April, down slightly from the previous two months and seemingly a period of calming inflation pressures following January’s 0.5% spike.

Europe

STOXX Europe 600 Index ended 0.46% lower as hotter-than-expected eurozone inflation increased uncertainty about policy easing by the European Central Bank (ECB) beyond June. Major stock indexes also fell over this period. France’s CAC 40 Index dropped 1.26%, while Germany’s DAX declined 1.05%. Italy’s FTSE MIB ended the week flat. The UK’s FTSE 100 Index lost 0.51%.

Japan

Japan’s stock markets generated mixed weekly returns, with the Nikkei 225 Index falling 0.4% and the broader TOPIX Index gaining 1.1%. A downward revision to U.S. economic growth data increased the likelihood that the Federal Reserve may cut interest rates at least once before the end of this year, lending some support to risk appetite globally.

China

Chinese equities were little changed after an unexpectedly weak manufacturing reading highlighted growth headwinds on the economy. The Shanghai Composite Index was broadly flat, while the blue chip CSI 300 gave up 0.6%. In Hong Kong, the benchmark Hang Seng Index lost 2.84%.

Disclaimer

Information contained in this material is obtained from sources believed to be reliable, however, there is neither representation, warranty nor guarantee, in any manner that accuracy, completeness, timeliness, reliability or suitability expressed or implied for any purpose that users of the material may be intended. Users or any third parties acknowledge that Investbanq Pte. Ltd. (“Paladigm”), its information providers or any related licensors or employees shall not be held liable for or to any contractual, tortuous liability, damage or consequence including but not limited to lost opportunity in connection with the use of the information in any way claimed to be arising.

Paladigm may discontinue or make changes in the information, products or services in this material at any time without prior notice to users.

No solicitation or offer of any investment instruments or services in any jurisdiction shall be constructed.

Information including but not limited to financial data, commentary or any other materials contained in the material is the properties of Paladigm, unless written consent from Paladigm is obtained, no information may, in any manner, be copied, transmitted, disseminated, sold, distributed, published, broadcasted, circulated for any purpose, cause or reason.

Materials related to certain investment tools of which authorization has not been obtained is not intended to, and shall not, be distributed or circulated publicly. Readers acknowledge that access to those materials is taken on readers' own initiative.

There can be no assurance that the investment objectives of any program, products or services will be met. Past performance is not necessarily indicative of future results. Futures and options trading involves substantial risk of loss. An investor could potentially lose more than the initial investment. Investor must read current agreements and any applicable supplements before they invest.

Contact us

Leave your contact details and our manager will be in touch as soon as possible to provide advice on any questions you may have.

By sending this request you consent to the processing and storage of your personal data according to Privacy Policy.